Teva loses IRA drug pricing challenge in DC federal court news2025-11-21T19:19:47+00:00November 21st, 2025|Endpoints News|
Sarepta ends Elevidys trial with Hansa’s pre-treatment; Some pipeline cuts at Modernanews2025-11-21T16:12:27+00:00November 21st, 2025|Endpoints News|
FDA investigates child death potentially related to Takeda’s enzyme replacement therapynews2025-11-21T16:11:24+00:00November 21st, 2025|Endpoints News|
Novo, Lilly begin to sell obesity medications directly to employersnews2025-11-21T15:56:08+00:00November 21st, 2025|Endpoints News|
Lilly becomes first $1 trillion pharma companynews2025-11-21T15:24:53+00:00November 21st, 2025|Endpoints News|
Contineum’s J&J-partnered drug fails Phase 2 multiple sclerosis trialnews2025-11-21T15:19:47+00:00November 21st, 2025|Endpoints News|
GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing dealnews2025-11-21T12:07:36+00:00November 21st, 2025|Endpoints News|
Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb’s next movenews2025-11-21T12:00:57+00:00November 21st, 2025|Endpoints News|
Under RFK Jr., vaccine use has slid while suspicion risesnews2025-11-20T20:47:17+00:00November 20th, 2025|Endpoints News|
Pentagon-backed Lumen is ready to drastically slash antibody manufacturing costsnews2025-11-20T20:46:37+00:00November 20th, 2025|Endpoints News|
